# Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa

> **NCT07006246** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Professor Francois Venter** · enrollment: 1900 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Tenofovir disoproxil fumarate + lamivudine/emtricitabine (TDF+3TC /FTC)

## Key facts

- **NCT ID:** NCT07006246
- **Lead sponsor:** Professor Francois Venter
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-19
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 1900 (ESTIMATED)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07006246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07006246, "Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07006246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*